What is the CVSS score of CVE-2024-24377?

CVE-2024-24377 has a CVSS 3.1 base score of 9.8 (Critical). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 1.1%.

Is there a public PoC exploit available for CVE-2024-24377?

Yes, a public proof-of-concept exploit is available for CVE-2024-24377. Prioritise patching immediately. EPSS: 1.1%.

Idocview CVE-2024-24377

CRITICAL

Command Injection (CWE-77)

2024-02-16 cve@mitre.org

RCE Command Injection Idocview

9.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

9.8 CRITICAL

AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Feb 16, 2024 - 09:15 nvd

CRITICAL 9.8

DescriptionNVD

An issue in idocv v.14.1.3_20231228 allows a remote attacker to execute arbitrary code and obtain sensitive information via a crafted script.

AnalysisAI

An issue in idocv v.14.1.3_20231228 allows a remote attacker to execute arbitrary code and obtain sensitive information via a crafted script. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified as Command Injection (CWE-77), which allows attackers to inject arbitrary commands into system command execution. An issue in idocv v.14.1.3_20231228 allows a remote attacker to execute arbitrary code and obtain sensitive information via a crafted script. Affected products include: Idocv Idocview.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Use parameterized APIs, avoid shell execution, validate input with strict allowlists.